Myra Barbara Ladaga Castillo, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 115 Seymour Drive, Derby, VT 05829 Phone: 802-624-8011 |
Richard Coutu, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4408 Us Rte 5, Derby, VT 05829 Phone: 802-334-2313 Fax: 802-334-1675 |
Mary J Gagne, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 115 Seymour Drive, Wal-mart Pharmacy, Derby, VT 05829 Phone: 802-624-8011 |
Michael Thomas Kentoski, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4408 U.s. Route 5, Derby, VT 05829 Phone: 802-334-2313 |
News Archive
McKesson Corporation today reported that revenues for the third quarter ended December 31, 2011 were up 9% to $30.8 billion compared to $28.2 billion a year ago. On the basis of U.S. generally accepted accounting principles, third-quarter earnings per diluted share was $1.20 compared to $0.60 a year ago.
Dartmouth researchers studying rats have discovered that activation of designer neural receptors can suppress cravings in a brain region involved in triggering those cravings.
It is estimated that more than 5,000 cases of Vulvar Cancer were diagnosed in the United States in 2015, and approximately 1,000 women died from the disease[i]. In order to provide comprehensive, up-to-date clinical treatment guidelines for this rare cancer, the National Comprehensive Cancer Network, an alliance of 26 of the nation's leading cancer centers, has published the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Vulvar Cancer.
Oncolytics Biotech Inc. has announced that it has been granted U.S. Patent 7,264,798 entitled "Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells with a Virus."
› Verified 8 days ago